Maria Carmela Leo

Maria Carmela Leo

Auto-generated profile, based on publicly available information

Maria Carmela Leo

Meyer Children's Hospital

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in European Cardiology Review
Verified
Journal Article
Open access
Andrea BarucciAndrea Barucci
Andrea Barucci
VCValentina Colcelli
Valentina Colcelli
SMSalvatore De Masi
Salvatore De Masi
MFMartina Falconi
Martina Falconi
MLMaria Carmela Leo
Maria Carmela Leo
RPRoberto Pini
Roberto Pini
The rapid integration of artificial intelligence (AI) into clinical research is transforming the landscape of biomedical innovation, influencing numerous phases of research, with critical ethical and legal implications. Regulation (EU) 2024/1689, commonly referred to as the AI Act and issued in 2024, introduced a new regulatory framework that classifies AI systems used in clinical settings as ‘high risk’, requiring increased scrutiny by ethics committees and national authorities. This review addresses ethical and regulatory challenges and discusses the application of the AI Act within real-world clinical research. We propose a three-phase lifecycle (training, real-world testing and post-marketing monitoring) to align regulatory burdens with AI maturity. Our recommendations include transparent protocol design with explicit data-use declarations, complementary application of the Medical Device Regulation and the AI Act, with particular attention to the early research phases. This approach provides practical indications for researchers and operational evaluation criteria for ethics committees to ensure patient safety while fostering trustworthy AI deployment in clinical trials.